These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 1920939)

  • 41. Effect of serum fibroblast growth factor-23, matrix Gla protein and Fetuin-A in predicting osteoporosis in maintenance hemodialysis patients.
    Wu Q; Xiao DM; Fan WF; Ye XW; Niu JY; Gu Y
    Ther Apher Dial; 2014 Oct; 18(5):427-33. PubMed ID: 25196492
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aluminum bone content in dialysis osteodystrophy with secondary hyperparathyroidism.
    Pizzarelli F; Ballanti P; Costantini S; Mocetti P; Giordano R; Della Rocca C; Fabrizi F; Bonucci E; Maggiore Q
    Miner Electrolyte Metab; 1988; 14(2-3):129-34. PubMed ID: 3380068
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Determination of bone mineral content and correlations with calciotropic hormones in periodic hemodialysis patients].
    Anelli F; De Maio P; Girardi V; Papagni S; Rossi G; Cantatore FP; Carrozzo M
    Minerva Urol Nefrol; 1992; 44(4):265-73. PubMed ID: 1299008
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Aluminum and uremic bone disease. Diagnostic utility of serum aluminum and the deferoxamine (DFO) test ].
    Jarava C; Armas JR; Palma A
    Nefrologia; 2001; 21(2):174-81. PubMed ID: 11464651
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of secondary hyperparathyroidism in patients on maintenance hemodialysis.
    Okada K; Takahashi S; Nagura Y; Hatano M
    Nihon Jinzo Gakkai Shi; 1989 Oct; 31(10):1085-9. PubMed ID: 2615019
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Vitamin D metabolism and chronic kidney disease].
    Honda H; Sanada D; Akizawa T
    Clin Calcium; 2006 Jul; 16(7):1143-46. PubMed ID: 16816474
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Osteocalcin, skeletal alkaline phosphatase, and bone mineral content in very low birth weight infants: a longitudinal assessment.
    Pittard WB; Geddes KM; Hulsey TC; Hollis BW
    Pediatr Res; 1992 Feb; 31(2):181-5. PubMed ID: 1542549
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk factors leading to reduced bone mineral density in hemodialysis patients with metabolic syndrome.
    Binici DN; Gunes N
    Ren Fail; 2010 May; 32(4):469-74. PubMed ID: 20446786
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dialysate Calcium Concentration, Mineral Metabolism Disorders, and Cardiovascular Disease: Deciding the Hemodialysis Bath.
    Langote A; Ahearn M; Zimmerman D
    Am J Kidney Dis; 2015 Aug; 66(2):348-58. PubMed ID: 25958080
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Calcaneal osteopenia is a new marker for arterial stiffness in chronic hemodialysis patients.
    Joki N; Hase H; Shiratake M; Kishi N; Tochigi S; Imamura Y
    Am J Nephrol; 2005; 25(3):196-202. PubMed ID: 15870495
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Kidney and bone update : the 5-year history and future of CKD-MBD. Bone metabolic marker in hemodialysis patients update].
    Okuno S
    Clin Calcium; 2012 Jul; 22(7):1009-17. PubMed ID: 22750933
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Disorders of calcium metabolism at various times after renal transplantation.
    Babarykin D; Adamsone I; Amerika D; Folkmane I; Rozental R
    Ann Transplant; 1999; 4(1):46-53. PubMed ID: 10850601
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bone disease in renal failure. Clinical and histomorphometric studies.
    Nilsson P
    Scand J Urol Nephrol Suppl; 1984; 84():1-68. PubMed ID: 6393322
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Renal osteodystrophy in hemodialysis patients.
    Oda H; Yorioka N; Takemasa A; Shigemoto K; Harada S; Ito T; Masaki T; Yamakido M
    Hiroshima J Med Sci; 1995 Sep; 44(3):83-8. PubMed ID: 8567317
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endogenous estrogen may prevent bone loss in postmenopausal hemodialysis patients throughout life.
    Sugiya N; Nakashima A; Takasugi N; Kawai A; Kiribayashi K; Tanaka J; Kohno N; Yorioka N
    Osteoporos Int; 2011 May; 22(5):1573-9. PubMed ID: 20652228
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Rheumatologic and radiologic symptoms of secondary hyperparathyroidism: retrospective long-term study of 175 chronic hemodialysis patients].
    Mayet WJ; Hermann E; Wandel E; Elsen A; Schadmand S; Klose KJ; Poralla T; Meyer zum Büschenfelde KH; Köhler H
    Z Rheumatol; 1991; 50(5):313-9. PubMed ID: 1776368
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mineral metabolism and renal bone disease: effects of CAPD versus hemodialysis.
    Coburn JW
    Kidney Int Suppl; 1993 Feb; 40():S92-100. PubMed ID: 8445845
    [No Abstract]   [Full Text] [Related]  

  • 58. Parathormone and bone-specific alkaline phosphatase for the follow-up of bone turnover in hemodialysis patients: is it so simple?
    Delanaye P; Dubois BE; Jouret F; Krzesinski JM; Moranne O; Cavalier E
    Clin Chim Acta; 2013 Feb; 417():35-8. PubMed ID: 23262367
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Calcium and phosphorus in diet therapy of uremia.
    Schoolwerth AC; Engle JE
    J Am Diet Assoc; 1975 May; 66(5):460-4. PubMed ID: 1123506
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative evaluation of bone aluminum content and bone histology in patients on chronic hemodialysis and hemofiltration.
    Sebert JL; Fournier A; Leflon P; Fohrer P; de Frémont JF; Morinière P; Galy C; Marie A; Demontis R; Boudailliez B
    Nephron; 1986; 42(1):34-40. PubMed ID: 3941748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.